लोड हो रहा है...
Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis
Leflunomide is a disease-modifying antirheumatic drug (DMARD) that has been in routine clinical use for the treatment of rheumatoid arthritis (RA) and psoriatic arthritis for a decade. In RA, clinical trials of up to two years’ duration showed that leflunomide monotherapy was equivalent to methotrex...
में बचाया:
| में प्रकाशित: | Open Access Rheumatol |
|---|---|
| मुख्य लेखकों: | , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Dove Medical Press
2010
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5074775/ https://ncbi.nlm.nih.gov/pubmed/27789998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OARRR.S9448 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|